Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Rassam

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Haematology|January 1, 1989
A myelokathexis-like variant of myelodysplasiaS M Rassam, P Roderick, I al-Hakim, et al.
Clinical Science (London, England : 1979)|June 1, 1994
Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemiaV Patel, S M Rassam, H C Chen, et al.
The British Journal of Ophthalmology|January 1, 1994
Accurate vessel width measurement from fundus photographs: a new conceptS M Rassam, V Patel, O Brinchmann-Hansen, et al.
Metabolism: Clinical and Experimental|December 29, 1998
Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjectsV Patel, S M Rassam, H C Chen, et al.
Eye (London, England)|January 1, 1994
Vessel diameter changes during the cardiac cycleH C Chen, V Patel, J Wiek, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Retinal vessel measurement: comparison between observer and computer driven methodsR S Newsom, P M Sullivan, S M Rassam, et al.
Leukemia|December 1, 1992
Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literatureD R Betts, A Z Rohatiner, M L Evans, et al.
Seminars in Oncology|December 1, 1993
Idarubicin for remission induction of acute myeloid leukemia: United Kingdom multicenter experienceS M Rassam, A Turker, R L Powles, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
Blood|September 6, 2001
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1HC E Dearden, E Matutes, B Cazin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Haematology|January 1, 1989
A myelokathexis-like variant of myelodysplasiaS M Rassam, P Roderick, I al-Hakim, et al.
Clinical Science (London, England : 1979)|June 1, 1994
Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemiaV Patel, S M Rassam, H C Chen, et al.
The British Journal of Ophthalmology|January 1, 1994
Accurate vessel width measurement from fundus photographs: a new conceptS M Rassam, V Patel, O Brinchmann-Hansen, et al.
Metabolism: Clinical and Experimental|December 29, 1998
Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjectsV Patel, S M Rassam, H C Chen, et al.
Eye (London, England)|January 1, 1994
Vessel diameter changes during the cardiac cycleH C Chen, V Patel, J Wiek, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Retinal vessel measurement: comparison between observer and computer driven methodsR S Newsom, P M Sullivan, S M Rassam, et al.
Leukemia|December 1, 1992
Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literatureD R Betts, A Z Rohatiner, M L Evans, et al.
Seminars in Oncology|December 1, 1993
Idarubicin for remission induction of acute myeloid leukemia: United Kingdom multicenter experienceS M Rassam, A Turker, R L Powles, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
Blood|September 6, 2001
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1HC E Dearden, E Matutes, B Cazin, et al.
Pageof 3